First Time Loading...

Zimmer Biomet Holdings Inc
NYSE:ZBH

Watchlist Manager
Zimmer Biomet Holdings Inc Logo
Zimmer Biomet Holdings Inc
NYSE:ZBH
Watchlist
Price: 119.35 USD -0.33% Market Closed
Updated: Apr 28, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

21.5B
+1%
Assets
Growth Rates:
1 Year
+2%
3 Years
-12%
5 Years
-11%
7 Years
-19%
10 Years
+124%
9B
+4%
Liabilities
Growth Rates:
1 Year
0%
3 Years
-26%
5 Years
-30%
7 Years
-47%
10 Years
+175%
12.5B
-0.2%
Equity
Growth Rates:
1 Year
+4%
3 Years
+2%
5 Years
+11%
7 Years
+29%
10 Years
+98%

Balance Sheet Decomposition
Zimmer Biomet Holdings Inc

21.5B
Assets
9B
Liabilities
21.5B
Assets
9B
Liabilities
Current Assets 4.6B
Cash & Short-Term Investments 415.8m
Receivables 1.4B
Other Current Assets 2.8B
Non-Current Assets 16.9B
PP&E 2.1B
Intangibles 13.7B
Other Non-Current Assets 1.2B
Current Liabilities 2.9B
Accounts Payable 410.6m
Accrued Liabilities 417.1m
Other Current Liabilities 2B
Non-Current Liabilities 6.2B
Long-Term Debt 4.9B
Other Non-Current Liabilities 1.3B

Balance Sheet
Zimmer Biomet Holdings Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
1 083
1 459
634
524
543
618
802
479
376
416
Cash Equivalents
1 083
1 459
634
524
543
618
802
479
376
416
Short-Term Investments
613
165
0
0
0
0
0
0
0
0
Total Receivables
912
1 447
1 604
1 544
1 276
1 364
1 453
1 405
1 382
1 442
Accounts Receivables
912
1 447
1 604
1 544
1 276
1 364
1 453
1 405
1 382
1 442
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
1 193
2 254
1 959
2 068
2 257
2 385
2 451
2 395
2 147
2 385
Other Current Assets
513
530
466
429
352
357
378
607
523
732
Total Current Assets
4 313
5 854
4 664
4 565
4 427
4 724
5 083
4 885
4 427
4 610
PP&E Net
1 285
2 063
2 038
2 039
2 015
2 344
2 322
2 288
2 069
2 264
PP&E Gross
1 285
2 063
2 038
2 039
2 015
2 344
2 322
2 288
2 069
2 264
Accumulated Depreciation
2 122
2 365
2 634
3 045
3 422
3 839
4 277
4 719
4 586
4 706
Intangible Assets
604
8 746
8 785
8 353
7 685
7 258
7 056
6 300
5 064
4 856
Goodwill
2 514
9 934
10 644
10 668
9 594
9 600
9 262
9 192
8 580
8 819
Other Long-Term Assets
942
564
554
389
405
713
695
792
926
948
Other Assets
2 514
9 934
10 644
10 668
9 594
9 600
9 262
9 192
8 580
8 819
Total Assets
9 658
N/A
27 161
+181%
26 684
-2%
26 014
-3%
24 127
-7%
24 639
+2%
24 418
-1%
23 456
-4%
21 066
-10%
21 497
+2%
Liabilities
Accounts Payable
145
285
365
330
363
401
330
351
354
411
Accrued Liabilities
639
0
1 090
1 030
931
1 156
1 285
1 162
972
1 098
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
576
1 225
525
1 500
500
1 605
544
900
Other Current Liabilities
240
1 333
352
484
603
384
442
350
488
449
Total Current Liabilities
1 024
1 618
2 382
3 070
2 421
3 442
2 557
3 468
2 358
2 857
Long-Term Debt
1 426
11 497
10 666
8 918
8 399
6 715
7 627
5 464
5 152
4 868
Deferred Income Tax
46
3 150
3 031
1 102
1 000
840
790
666
475
358
Minority Interest
2
2
1
0
5
5
5
6
7
8
Other Liabilities
611
1 006
936
1 190
1 031
1 249
1 245
1 193
1 054
926
Total Liabilities
3 108
N/A
17 273
+456%
17 016
-1%
14 278
-16%
12 856
-10%
12 251
-5%
12 224
0%
10 796
-12%
9 046
-16%
9 017
0%
Equity
Common Stock
3
3
3
3
3
3
3
3
3
3
Retained Earnings
8 362
8 348
8 467
10 023
9 491
10 427
10 087
10 292
9 559
10 385
Additional Paid In Capital
4 331
8 195
8 369
8 515
8 686
8 920
9 122
9 315
9 504
9 846
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
0
Treasury Stock
6 184
6 329
6 736
6 722
6 722
6 721
6 720
6 718
6 867
7 562
Other Equity
39
329
434
83
187
242
298
232
179
191
Total Equity
6 550
N/A
9 888
+51%
9 669
-2%
11 736
+21%
11 271
-4%
12 388
+10%
12 194
-2%
12 661
+4%
12 020
-5%
12 480
+4%
Total Liabilities & Equity
9 658
N/A
27 161
+181%
26 684
-2%
26 014
-3%
24 127
-7%
24 639
+2%
24 418
-1%
23 456
-4%
21 066
-10%
21 497
+2%
Shares Outstanding
Common Shares Outstanding
170
203
201
203
204
206
208
209
209
206

See Also

Summary
ZBH intrinsic value, competitors valuation, and company profile.
DCF Valuation
ZBH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ZBH stock valuation using valuation multiples.
Wall Street Estimates
ZBH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ZBH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 132,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.